The science is in: Aspirin for CVD primary prevention is out

Nevertheless, the practice is still widespread globally despite being controversial

Aspirin for primary prevention of cardiovascular events is ‘out’ in the wake of a landmark review, a leading researcher says.

Professor Mark Nelson, chair of general practice at the University of Tasmania, says the science is now “pretty much settled”.